Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
ALPHARETTA, Ga., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email